Corteva (CTVA)

NYSE Materials Fertilizers & Agricultural Chemicals S&P MidCap 400
$11.90
-0.14 (-1.16%)
Close of Nov 06, 2026 · end-of-day data

CTVA 8-K filings in 2026

Every material Form 8-K Corteva filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2026815 on record in all
Latest filing in 2026Oct 07, 2026leadership
High impact (4-5)6of 8 briefs
TonePositive1Mixed2Neutral5
leadership 3earnings 3restructuring 1financing 1
Oct 7, 5:09 PM ET

Corteva names Luke Kissam CEO and Jeff Rudolph CFO as Separation takes effect

Neutral leadership Written later 5.02

Corteva disclosed board and officer changes tied to its Separation, effective at the Effective Time. Luther (Luke) Kissam became Chief Executive Officer and Jeff Rudolph became Chief Financial Officer, and four directors resigned from the board. Shareholders will be watching how the new leadership team and reshaped board guide the company after the Separation.

  • Luther (Luke) Kissam was appointed Chief Executive Officer, and Jeff Rudolph was appointed Chief Financial Officer, effective as of the Effective Time.
  • Charles V. Magro, Kerry J. Preete, Marcos M. Lutz and Karen H. Grimes resigned from the Board, with Magro also leaving his officer roles.
  • Kissam was appointed as a director, and Brook Cunningham and Ralph Ford were named Chief Commercial Officer and Chief Integrated Operations Officer.
Read the filing on SEC.gov ↗
Oct 5, 5:27 PM ET

Corteva completes spin-off of seed business as Vylor Inc. begins trading as VYLR

Neutral restructuring Written later 1.012.01

Corteva completed the separation of its seed operating segment into an independent public company, Vylor Inc., through a pro rata share distribution effective October 1, 2026. Vylor common stock began regular-way trading on the New York Stock Exchange under the symbol VYLR that day, and Corteva entered several agreements with Vylor governing the split, including tax, employee, transition services, and intellectual property terms.

  • Distribution record date was September 24, 2026; Vylor shares trade on the NYSE as VYLR from October 1, 2026
  • Separation and Distribution Agreement dated September 29, 2026; Tax Matters, Employee Matters, Reverse Transition Services, Intellectual Property Matters, and Global Master Seed Treatment Supply agreements dated October 1, 2026
  • Certain schedules omitted under Item 601(a)(5) of Regulation S-K; the filing does not give financial figures for the spin-off
Read the filing on SEC.gov ↗
Aug 20, 4:32 PM ET

Corteva signs bond indenture amendments tied to Vylor seed spin-off

Neutral financing Written later 1.013.03

Corteva's subsidiary EIDP entered a supplemental indenture on August 20, 2026, that removes most restrictive covenants and events of default from its notes, with the changes taking effect only when Vylor's exchange offers settle alongside the separation. The filing says the amendments were approved by the required majority of noteholders as of August 19, 2026, and would not take effect if the separation is not completed.

  • On August 20, 2026, EIDP entered a fourth supplemental indenture with U.S. Bank Trust Company as trustee.
  • The proposed amendments would eliminate substantially all restrictive covenants and events of default, other than payment and bankruptcy-related defaults.
  • Vylor received the required consents from noteholders as of August 19, 2026; the amendments become operative only at settlement of the exchange offers, expected alongside the separation.
Read the filing on SEC.gov ↗
Jul 30, 4:44 PM ET

Corteva raises 2026 outlook as Q2 sales dip 1% and GAAP EPS falls 10%

Mixed earnings Written later 2.02

Corteva reported second-quarter 2026 net sales of $6.38 billion, down 1% from a year earlier, and GAAP earnings per share from continuing operations of $1.81, down 10%. Non-GAAP operating EBITDA rose 4% to $2.26 billion and operating EPS rose 5% to $2.30, and the company raised its full-year 2026 guidance to operating EBITDA of $4.1 billion to $4.3 billion and operating EPS of $3.60 to $3.80 per share.

  • Q2 2026 net sales were $6.38 billion, down 1%; organic sales fell 2%
  • GAAP EPS from continuing operations was $1.81 versus $2.02 in the year-earlier quarter; GAAP income from continuing operations after taxes was $1.22 billion
  • Full-year 2026 operating EBITDA guidance is $4.1 billion to $4.3 billion; operating EPS guidance is $3.60 to $3.80 per share
  • The planned separation remains on track for an October 1, 2026 spin-off of Vylor, with an Investor Day on September 15, 2026
Read the filing on SEC.gov ↗
Jun 29, 5:23 PM ET

Corteva directors Grimes, Lutz, Magro and Preete to resign ahead of Vylor seed spin-off

Neutral leadership Written later 5.027.01

Four Corteva directors, Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete, agreed to resign from the Corteva board effective immediately before the planned spin-off of the seed business into Vylor, Inc. The filing says each is expected to join the Vylor board, and the resignations are not tied to any disagreement with the company. The companies also announced their post-separation boards, and the separation remains on track for the fourth quarter of 2026.

  • Resignations agreed June 26, 2026, and take effect only if the spin-off is completed
  • Greg Page to chair a nine-person Corteva board; Luke Kissam to join at separation
  • Karen Grimes to chair a seven-director Vylor board; a search is ongoing for at least one more member
  • Vylor filed its first Form 10 registration statement with the SEC; separation on track for 4Q 2026
Read the filing on SEC.gov ↗
May 5, 4:41 PM ET

Corteva Q1 2026 sales rise 11% to $4.9 billion; 2026 guidance reaffirmed

Positive earnings Written later 2.02

Corteva reported first-quarter 2026 net sales of $4.9 billion, up 11% from a year earlier, and GAAP earnings per share from continuing operations of $1.07 versus $0.97. The company reaffirmed its full-year 2026 guidance, which keeps Operating EBITDA at $4.0 billion to $4.2 billion and Operating EPS at $3.45 to $3.70, while the planned separation remains on track for the second half of 2026.

  • Net sales were $4.9 billion, up 11%; organic sales rose 7%.
  • GAAP EPS from continuing operations was $1.07, up from $0.97; Operating EPS was $1.50, up 33%.
  • Full-year 2026 guidance reaffirmed: Operating EBITDA $4.0 billion to $4.2 billion; Operating EPS $3.45 to $3.70.
  • The company plans to repurchase about $500 million of shares in the first half of 2026.
Read the filing on SEC.gov ↗
Apr 14, 8:35 AM ET

Corteva names Luke Kissam CEO of New Corteva; leadership set for Q4 2026 spin-off

Neutral leadership Written later 5.027.01

Corteva named Luke Kissam, former Albemarle chairman, president and CEO, as CEO of New Corteva, the crop protection company that will separate from its seed business, SpinCo, in the fourth quarter of 2026. Kissam joins the company June 1, 2026, and Chief Executive Chuck Magro will become SpinCo CEO at separation, with new executive teams named for both companies. The filing discloses no financial results; the changes set the leadership structure for the planned separation.

  • Luke Kissam, 61, joins June 1, 2026 as CEO of the Crop Protection Business Unit and becomes New Corteva CEO at separation.
  • Kissam's employment agreement sets a $1.2 million annual base salary, a 150% short-term incentive target, and a one-time 2026 equity award with a $3.75 million target grant date value.
  • Jeff Rudolph is named New Corteva CFO; David Johnson becomes SpinCo CFO; Magro becomes SpinCo CEO.
  • Robert King, Executive Vice President of Crop Protection, becomes a strategic advisor July 1, 2026, and leaves after 2026 year-end, eligible for a $1 million transition bonus.
Read the filing on SEC.gov ↗
Feb 3, 4:44 PM ET

Corteva Q4 sales fall 2% to $3.91 billion, GAAP loss $537 million; full-year profit rises 40%

Mixed earnings Written later 2.02

Corteva reported fourth-quarter 2025 net sales of $3.91 billion, down 2%, and a GAAP loss from continuing operations of $537 million, or $0.80 per share. For full-year 2025, net sales rose 3% to $17.40 billion and GAAP income from continuing operations rose 40% to $1.20 billion, or $1.75 per share. The company also expects 2026 operating EBITDA of $4.0 billion to $4.2 billion and operating EPS of $3.45 to $3.70 per share.

  • Q4 2025 operating EPS was $0.22, down 31% from the prior year, and operating EBITDA was $446 million, down 15%.
  • FY 2025 operating EPS was $3.34, up 30%, and free cash flow was $2.9 billion, a 69% improvement.
  • A Bayer litigation resolution involves a $610 million cash outflow, largely in the first quarter of 2026.
  • Corteva remains on track to complete its planned separation in the second half of 2026.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Corteva filing is on SEC EDGAR ↗. 8-K briefs of other companies →